| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000236943.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004368321 |
Resistant |
| ENSG00000236943.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.022187833 |
Resistant |
| ENSG00000236943.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.004650745 |
Resistant |
